drugset / Trial / NCT07020104

The Role of Skin Sodium Accumulation in Chronic Kidney Disease

NCT07020104

RandomizedCrossoverOpen-labelOther

Summary

This project consists of four substudies: a cohort study (A) and a sodium intake intervention (B) and a sodium excretion intervention (C) and a water intervention study (D). The main objective of the cohort study (A) is to investigate the prognostic implications of tissue sodium accumulation in CKD patients. The primary objective of the sodium intervention studies is to study the effect of high and low sodium intake (B) and increased renal sodium excretion (C) on tissue sodium content. The main objective of the water intervention study (D) is to investigate the effect of increased and habitual water intake on tissue sodium content and transepidermal water loss.

Timeline

Start
2025-01-07
Primary completion
2039-12-01
Completion
2039-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrochlorothiazide Unknown 12.5 mg
Subject Hydrochlorothiazide Unknown 25 mg
Subject Lercanidipine Small molecule 10 mg
Subject Lercanidipine Small molecule 20 mg
Subject Spironolactone Small molecule 12.5 mg
Subject Spironolactone Small molecule 25 mg